The Center for Alzheimer’s Disease Research is committed to catalyzing discovery into Alzheimer’s disease and related disorders and speeding the race to treatments.
More than six million people in the United States are living with Alzheimer’s disease. By 2050, this number is expected to rise to nearly 13 million. Alzheimer’s is the only cause of death in the top 10 nationally with no known cure. In order to advance prevention, treatments and cures, the Center for Alzheimer’s Disease Research bridges foundational research and clinical studies and supports collaborative thinking across multiple disciplines. The center brings together basic science researchers, clinicians and physician-scientists at Brown and its affiliated hospitals, including Butler Hospital, Rhode Island Hospital, Women and Infants Hospital and the Providence VA Medical Center.
- Brown has major strengths in brain science, biology and bioinformatics, with research programs in Alzheimer’s disease risk genes, neurodegeneration, aging and neuron-glial cell interactions.
- Clinical faculty members have an international reputation in diagnosis and treatment. They are leaders in clinical trials at the memory and aging clinics at Butler Hospital and Rhode Island Hospital.
- The center fosters research on questions essential to changing disease trajectory: how, where and when does Alzheimer’s disease begin? The center facilitates discovery research informed by genetic and biomarker data.
Alzheimer’s and other neurodegenerative diseases require collaborative thinking across disciplines in both basic and clinical research to generate the knowledge we need to advance prevention, treatments and cures.